Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal HIF-1 alpha Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat, Goat, Hamster, Rabbit, Primate |
| Conjugation | Unconjugated |
| Immunogen | A fusion protein including residues 530-825 of the mouse HIF-1 alpha protein. [UniProt# Q61221] |
Rabbit Polyclonal HIF-1 alpha Antibody
| Applications | IHC, IP, WB |
| Reactivities | Human, Mouse, Rat, Canine, Guinea Pig, Primate, Xenopus |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein made to an internal sequence of human HIF-1 alpha (containing amino acids 432-528) [UniProt Q16665] |
Rabbit Polyclonal HDAC9 Antibody
| Applications | WB |
| Reactivities | Human, Bovine, Canine, Primate |
| Conjugation | Unconjugated |
| Immunogen | A portion of amino acids 100-150 of human HDAC-9 was used as the immunogen. |
Rabbit Polyclonal NFkB p65 NLS Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Bovine, Equine, Primate |
| Conjugation | Unconjugated |
| Immunogen | A portion of the NFkB p65 NLS nuclear localization signal (NLS) (amino acids DTDDRHRIEEKRKRKT) was used as the immunogen for this antibody. |
Rabbit Polyclonal HES-1 Antibody
| Applications | IHC |
| Reactivities | Bovine, Human, Mouse, Primate, Rat |
| Conjugation | Unconjugated |
| Immunogen | A portion of amino acids 230-280 of human HES1 was used as the immunogen. |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Primate
Applications
- IHC
Families
- Transcription Factors
Filter by
Target Symbol
Antibody Hosts
Isotypes
Clonalities
Conjugates
Pathways
- Pathways in cancer (7)
- Wnt signaling pathway (4)
- Apoptosis (3)
- Colorectal cancer (3)
- MAPK signaling pathway (3)
- Pancreatic cancer (3)
- Prostate cancer (3)
- Renal cell carcinoma (3)
- mTOR signaling pathway (3)
- Adherens junction (2)
- Adipocytokine signaling pathway (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Basal cell carcinoma (2)
- Cell cycle (2)
- Chronic myeloid leukemia (2)
- Endometrial cancer (2)
- NOD-like receptor signaling pathway (2)
- Neurotrophin signaling pathway (2)
- RIG-I-like receptor signaling pathway (2)
- Small cell lung cancer (2)
- T cell receptor signaling pathway (2)
- TGF-beta signaling pathway (2)
- Thyroid cancer (2)
- Toll-like receptor signaling pathway (2)
- Acute myeloid leukemia (1)
- Allograft rejection (1)
- Alzheimer's disease (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Asthma (1)
- B cell receptor signaling pathway (1)
- Bladder cancer (1)
- Chemokine signaling pathway (1)
- Cytokine-cytokine receptor interaction (1)
- Cytosolic DNA-sensing pathway (1)
- Dilated cardiomyopathy (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Fc epsilon RI signaling pathway (1)
- Focal adhesion (1)
- Glioma (1)
- Graft-versus-host disease (1)
- Hematopoietic cell lineage (1)
- Huntington's disease (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Leukocyte transendothelial migration (1)
- Maturity onset diabetes of the young (1)
- Melanogenesis (1)
- Melanoma (1)
- Natural killer cell mediated cytotoxicity (1)
- Non-small cell lung cancer (1)
- Notch signaling pathway (1)
- Pathogenic Escherichia coli infection (1)
- Systemic lupus erythematosus (1)
- Tight junction (1)
- Type I diabetes mellitus (1)
- Type II diabetes mellitus (1)
- p53 signaling pathway (1)